The ADDovenom team gathered at the Liverpool School of Tropical Medicine for this year’s annual meeting (12-13 September), discussing progress towards the production of the next-generation of snakebite treatments.
Researchers from University of Bristol, LSTM, iBET, University of Liège, and Aix-Marseille University were joined by Scientific Advisory Board members Gerard Lambeau and Stefanos Grammatikos for two days of presentations and discussions.
The meeting began with a tour of LSTM’s Herpetarium, “one of the largest and most diverse collections of venomous snakes in Europe”.
The tour included watching Paul Rowley and Nick Casewell extract venom from several snakes. The venom is used in their “own basic science research and therapeutic research, shared among collaborators worldwide, and has been used to supply antivenom manufactures”.